Mark Jit

Datos Biográficos

ID1731891
NOMBREMark Jit
NOMBRESMark
APELLIDOJit
FIRMAJIT M
AFILIACIONESLondon School of Hygiene & Tropical Medicine
ORCID0000-0001-6658-8255
VERIFICADOSí
TOTAL DE OBRAS39
TOTAL DE CITAS3
TOTAL COMO AUTOR39
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2008
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H1

  • Estimating the basic reproduction number of measles in low-and middle-income settings using 172 seroprevalence studies

    Open AccessHan Fu, Alyssa N Sbarra et al.ARTICLEPLOS Global Public Health2026

    The basic reproduction number, R 0 , is an epidemiological measure to describe the transmissibility of infectious diseases and evaluate the potential effect of interventions. Measles R 0 has historically been considered to be between 12–18, with contextual factors contributing to its heterogeneity, but has rarely been estimated using data across multiple countries. Our study aims to estimate measles R 0 in low- and middle-income countries using a…

  • Defeating Disinformation

    Open AccessEric Goldman, Christoph Busch et al.BOOKDefeating Disinformation2025

    Global platforms present novel challenges. They are powerful conduits of commerce and global community, and their potential to influence behavior is enormous. Defeating Disinformation explores how to balance free speech and dangerous online content to reduce societal risks of digital platforms. The volume offers an interdisciplinary approach, drawing upon insights from different geographies and parallel challenges of managing global phenomena wit…

  • The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines

    Open AccessNichola R Naylor, Mateusz Hasso-Agopsowicz et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: Antibiotic resistance (ABR) may increase hospital costs, utility loss and mortality risk per patient. Understanding these losses at national, regional and global scales is necessary for efficiently tackling ABR. Our aim is to estimate the global economic burden of antibiotic-resistant infections and the potential for bacterial vaccines to mitigate this burden. METHODS: We take healthcare system and labour productivity perspectives. …

  • Vaccination strategies against wild poliomyelitis in polio-free settings

    Open AccessMegan Auzenbergs, Kaja Abbas et al.ARTICLEBMJ Global Health2025

    The 2021 importation of wild poliovirus serotype 1 (WPV1) into Malawi with subsequent international spread represented the first WPV1 cases in Africa since 2016. Preventing importations and spread of WPV1 is critical and dependent on population immunity provided through routine immunisation (RI) and supplementary immunisation activities (SIAs). We aim to estimate outbreak risk and costs, given the importation of WPV1 for non-endemic countries in …

  • Estimating the economic burden of invasive non-typhoidal Salmonella infections in low- and middle-income countries

    Open AccessJung-Seok Lee, Yongha Hwang et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: (iNTS) disease is a global health concern, particularly for sub-Saharan Africa. Despite high case fatality risks, there is no vaccine available against the disease. An obstacle to vaccine development is a lack of data on the economic burden of iNTS disease in many parts of the world. The main aim of the current study is to estimate the economic burden of iNTS disease in 123 countries. METHODS: Several multivariate regression models …

  • Enhancing global health security responses through greater inclusion of the global south in infectious disease modelling

    Open AccessKathy Leung, Alex R Cook et al.ARTICLEBMJ Global Health2025

    BOX Gaps continue to persist in global public health responses and greater inclusion of the Global South in infectious disease modelling is crucial for improving global health security

  • Long-term healthcare utilisation, costs and quality of life after invasive group B Streptococcus disease

    Open AccessFarah Seedat, Simon R Procter et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: disease (iGBS) on economic costs or health-related quality of life (HRQoL) in low-income and middle-income countries. We assessed the impact of iGBS on healthcare utilisation, costs and HRQoL in Argentina, India, Kenya, Mozambique and South Africa. METHODS: Inpatient and outpatient visits, out-of-pocket (OOP) healthcare payments in the 12 months before study enrolment, and health-state utility of children and caregivers (using the E…

  • Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand

    Open AccessSimon R Procter, Naomi R Waterlow et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Thailand was one of the first low- and middle-income countries to publicly fund seasonal influenza vaccines, but the lack of predictability in the timing of epidemics and difficulty in predicting the dominant influenza subtypes present a challenge for existing vaccines. Next-generation influenza vaccines (NGIVs) are being developed with the dual aims of broadening the strain coverage and conferring longer-lasting immunity. However, …

  • The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya

    Open AccessJoyce U Nyiro, Bryan O Nyawanda et al.ARTICLEBMC Public Health2024

    RSV-associated disease among young children leads to a substantial economic burden to both families and the health system in Kenya. This burden may differ between Counties in Kenya and similar multi-site studies are advised to support cost-effectiveness analyses

  • Between now and later

    Open AccessVivian Wan-Cheong Yim, Qianyun Wang et al.ARTICLEBMC Public Health2024

    In urban areas, Chinese caregivers' intent to delay vaccination in favour of 9vHPV vaccine over receiving the more accessible options was influenced by a mix of individual and contextual factors. Focussed health communication strategies are needed to accelerate HPV vaccination among adolescents

  • The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries

    Open AccessAllison Portnoy, Rebecca A Clark et al.ARTICLEBMJ Global Health2023

    INTRODUCTION: One in two patients developing tuberculosis (TB) in low-income and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and economic benefits would be distributed across income quintiles. METHODS: We modelled the impact of introducing TB vaccines meeting the World Health Organization preferred product characteristics…

  • Analyses of the return on investment of public health interventions

    Open AccessHugo C Turner, Yoshiaki Hori et al.ARTICLEBMJ Global Health2023

    Return on investment (ROI) analysis is increasingly being used for evaluating the value for money of public health interventions. Given its potential role for informing health policies, it is important that there is a more comprehensive understanding of ROI analysis within the global health field. To address this gap in the literature, we conducted a scoping review of recent research articles reporting an ROI metric for a health intervention with…

  • Is there a role for RDTs as we live with Covid-19? An assessment of different strategies

    Open AccessGabrielle Bonnet, Anna Vassall et al.ARTICLEBMJ Global Health2023

    INTRODUCTION: By 2022, high levels of past COVID-19 infections, combined with substantial levels of vaccination and the development of Omicron, have shifted country strategies towards burden reduction policies. SARS-CoV-2 rapid antigen tests (rapid diagnostic tests (RDTs)) could contribute to these policies by helping rapidly detect, isolate and/or treat infections in different settings. However, the evidence to inform RDT policy choices in low a…

  • Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries

    Open AccessAyala Levin, Ann Levin et al.ARTICLEBMJ Global Health2023

    BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a go…

  • Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries

    Open AccessHan Fu, Kaja Abbas et al.ARTICLEBMJ Global Health2023

    BACKGROUND: Microarray patches (MAPs) are a promising technology being developed to reduce barriers to vaccine delivery based on needles and syringes (N&S). To address the evidence gap on the public health value of applying this potential technology to immunisation programmes, we evaluated the health impact on measles burden and cost-effectiveness of introducing measles-rubella MAPs (MR-MAPs) in 70 low-income and middle-income countries (LMICs). …

  • Pay-it-forward influenza vaccination among older adults and children

    Open AccessFanny Fong-Yi Tang, Priya Kosana et al.ARTICLEPLOS Global Public Health2023

    A quasi-experimental study was conducted to evaluate the effectiveness of a pay-it-forward strategy for increasing influenza vaccination among children and older adults compared to a self-paid vaccination strategy in China. Pay-it-forward is an innovative community-engaged intervention in which participants receive a free influenza vaccination and are then asked if they would like to donate or create a message to support subsequent vaccinations. …

  • What, how and who

    Open AccessFrancis Ruiz, Sergio Torres‐rueda et al.ARTICLEPLOS Global Public Health2023

    While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources, cost-effectiveness analyses can inform key policy questions in the health technology assessment process. We carried out several cost-effectiveness analyses exp…

  • The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15–18-year-old adolescent girls compared to user-paid vaccination

    Open AccessYifan Li, Chuanyu Qin et al.ARTICLEBMC Public Health2023

    Chinese Clinical Trial Registry (ChiCTR), ChiCTR2200055542. Registered on 11 January 2022

  • The impact of Covid-19 vaccination in prisons in England and Wales

    Open AccessCiara V McCarthy, Oscar O’Mara et al.ARTICLEBMC Public Health2022

    The impact of vaccination in prison settings was highly dependent on early and rapid vaccine delivery. If administered to both those living and working in prison prior to an outbreak occurring, vaccines could substantially reduce COVID-19-related morbidity and mortality in prison settings

  • The local burden of disease during the first wave of the Covid-19 epidemic in England

    Open AccessEmily Nightingale, Emily S Nightingale et al.ARTICLEBMC Public Health2022

    Limitations in testing capacity biased the observed trajectory of COVID-19 infections throughout the first wave. Basing inference on COVID-19-related mortality and higher-coverage testing later in the time period, we could explore the extent of this bias more explicitly. Evidence points towards substantial under-representation of initial growth and peak magnitude of infections nationally, to which different parts of the country contribute unequal…

  • Challenges in ensuring global access to Covid-19 vaccines

    Open AccessOlivier J Wouters, Kenneth C Shadlen et al.ARTICLEThe Lancet2021

  • An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare

    Open AccessHugo C Turner, Rachel A Archer et al.ARTICLEFrontiers in Public Health2021

    Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as inconsistent methodologies, may be being used for informing health policy decisions. In addition, there is a lack of open access information and methodological guidance targeted to public health professio…

  • Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan

    Open AccessAllison Portnoy, Kaja Abbas et al.ARTICLEBMJ Global Health2021

    INTRODUCTION: Cervical cancer is the second most common cancer among women in Ethiopia, India, Nigeria and Pakistan. Our study objective was to assess similarities and differences in vaccine-impact projections through comparative modelling analysis by independently estimating the potential health impact of human papillomavirus (HPV) vaccination. METHODS: Using two widely published models (Harvard and Papillomavirus Rapid Interface for Modelling a…

  • Stark choices

    Open AccessSergio Torres‐rueda, Stuart Sweeney et al.ARTICLEBMJ Global Health2021

    OBJECTIVES: COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under different epidemiological scenarios. METHODS: We used country-specific epidemiological projections from a dynamic transmission model to dete…

  • Exploring equity in health and poverty impacts of control measures for Sars-CoV-2 in six countries

    Open AccessStuart Sweeney, Theo Prudencio Juhani Z Capeding et al.ARTICLEBMJ Global Health2021

    BACKGROUND: Policy makers need to be rapidly informed about the potential equity consequences of different COVID-19 strategies, alongside their broader health and economic impacts. While there are complex models to inform both potential health and macro-economic impact, there are few tools available to rapidly assess potential equity impacts of interventions. METHODS: We created an economic model to simulate the impact of lockdown measures in Pak…